SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-22-000078
Filing Date
2022-06-14
Accepted
2022-06-14 16:17:16
Documents
13
Period of Report
2022-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K opnt-20220614.htm   iXBRL 8-K 55027
  Complete submission text file 0001385508-22-000078.txt   234057

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20220614.xsd EX-101.SCH 2150
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20220614_def.xml EX-101.DEF 15433
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20220614_lab.xml EX-101.LAB 29833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20220614_pre.xml EX-101.PRE 16094
7 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20220614_htm.xml XML 14560
Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 221015091
SIC: 2834 Pharmaceutical Preparations